Therefore, the overexpression of JAK/STAT in colorectal tumors, reported elsewhere and positively associated with cancer advancement and poor prognosis [38], may explain the lower CCL2 expression in tumors compared to tumor-adjacent tissue observed in the present study. The gene discussed is CCL2; the disease is cancer.